作者
Claudia I. Henschke,Rudolf M. Huber,Long Jiang,Dawei Yang,Milena Čavić,Heidi Schmidt,Ella A. Kazerooni,Javier Zulueta,Ricardo Sales dos Santos,Luigi Ventura,Dawei Yang,Javier Zulueta,Lucia Viola,Anant Mohan,Choon‐Taek Lee,Milena Čavić,Heidi Schmidt,Ella A. Kazerooni,Ricardo Sales dos Santos,Anna Klinke,Claudia I. Henschke,Luigi Ventura,Long Jiang,Gabriella Sozzi,Martin C. Tammemägi,Stephen Lam,Rudolf M. Huber,Rowena Yip,Natthaya Triphuridet
摘要
Lung cancer screening using low-dose computed tomography (LDCT) carefully implemented has been found to reduce deaths from lung cancer. Optimal management starts with selection of eligibility criteria, counseling of screenees, smoking cessation, selection of the regimen of screening which specifies the imaging protocol, and workup of LDCT findings. Coordination of clinical, radiologic, and interventional teams and ultimately treatment of diagnosed lung cancers under screening determine the benefit of LDCT screening. Ethical considerations of who should be eligible for LDCT screening programs are important to provide the benefit to as many people at risk of lung cancer as possible. Unanticipated diseases identified on LDCT may offer important benefits through early detection of leading global causes of death, such as cardiovascular diseases and chronic obstructive pulmonary disease, as the latter may result from conditions such as emphysema and bronchiectasis, which can be identified early on LDCT. This report identifies the key components of the regimen of LDCT screening for lung cancer which include the need for a management system to provide data for continuous updating of the regimen and provides quality assurance assessment of actual screenings. Multidisciplinary clinical management is needed to maximize the benefit of early detection, diagnosis, and treatment of lung cancer. Different regimens have been evolving throughout the world as the resources and needs may be different, for countries with limited resources. Sharing of results, further knowledge, and incorporation of technologic advances will continue to accelerate worldwide improvements in the diagnostic and treatment approaches.